Scientists create 'Living Lab' from brain tumors to unlock treatment secrets
NCT ID NCT04865315
First seen Feb 02, 2026 · Last updated Jun 18, 2026 · Updated 25 times
Summary
This study collects tumor samples from 50 adults with low- or high-grade glioma to grow mini-tumors (organoids) in the lab. Researchers will study these organoids to learn why gliomas are so hard to treat and how they spread. The goal is to create personalized 'avatars' for testing new treatments, but this study does not offer a direct treatment or cure.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIGH GRADE GLIOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Maastricht Radiation Oncology
RECRUITINGMaastricht, Limburg, 6229ET, Netherlands
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.